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ABSTRACT
Bone sialoprotein-binding protein (Bbp), a MSCRAMMs
(Microbial Surface Components Recognizing Adhesive
Matrix Molecules) family protein expressed on the sur-
face of Staphylococcus aureus (S. aureus), mediates
adherence to ﬁbrinogen α (Fg α), a component in the
extracellular matrix of the host cell and is important for
infection and pathogenesis. In this study, we solved the
crystal structures of apo-Bbp273−598 and Bbp273−598-Fg
α561−575 complex at a resolution of 2.03 Å and 1.45 Å,
respectively. Apo-Bbp273−598 contained the ligand bind-
ing region N2 and N3 domains, both of which followed a
DE variant IgG fold characterized by an additional D1
strand in N2 domain and D1′ and D2′ strands in N3
domain. The peptide mapped to the Fg α561−575 bond to
Bbp273−598 on the open groove between the N2 and N3
domains. Strikingly, the disordered C-terminus in the
apo-form reorganized into a highly-ordered loop and a
β-strand G′′ covering the ligand upon ligand binding.
BbpAla298–Gly301 in the N2 domain of the Bbp273−598-Fg
α561−575 complex, which is a loop in the apo-form,
formed a short α-helix to interact tightly with the peptide.
In addition, BbpSer547–Gln561 in the N3 domain moved
toward the binding groove to make contact directly with
the peptide, while BbpAsp338–Gly355 and BbpThr365–Tyr387 in
N2 domain shifted their conﬁgurations to stabilize the
reorganized C-terminus mainly through strong hydro-
gen bonds. Altogether, our results revealed the molec-
ular basis for Bbp-ligand interaction and advanced our
understanding of S. aureus infection process.
KEYWORDS bone sialoprotein-binding protein (Bbp),
ﬁbrinogen, serine-aspartate repeat (Sdr), Microbial Surface
Components Recognizing Adhesive Matrix Molecules
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INTRODUCTION
Staphylococcus aureus (S. aureus) has been one of the
leading causes of bacterial infections worldwide. Each year,
some 500,000 patients in United States’ hospitals contract
staphylococcal infections. S. aureus resides as part of the
normal ﬂora in the healthy human body until there is damage
to skin surface or mucosal barrier, when it can gain access to
tissues or the bloodstream, ultimately resulting in a wide
range of infections and diseases, including impetigo, bac-
teremia, endocarditis, sepsis and arthritis (Lowy, 1998).
Several antibiotics have been introduced to successfully
treat S. aureus infections in patients over the past few dec-
ades. However, the infections became a growing concern
lately due to the emergence of highly virulent and antibiotic-
resistant strains, leading to increased morbidity and mortality
(Zetola et al., 2005). Effective vaccines against S. aureus at
early stages of infection are highly desirable, although all
efforts to develop these vaccines have failed to date
(Deresinski and Herrera, 2010; Vazquez et al., 2011).
S. aureus has evolved multiple strategies to promote
colonization and evade the immune system. The initial
adhesion of the pathogen to the extracellular matrix (ECM)
components of the host is believed to be a critical step for
successful infection. This is mediated by S. aureus surface
adhesins called Microbial Surface Components Recognizing
Adhesive Matrix Molecules (MSCRAMMs) (Gillaspy et al.,
1998; Patti et al., 1994). Several structurally related proteins
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characterized by serine-aspartate dipeptide repeats (SD
repeats) make up a family of MSCRAMMs (McCrea et al.,
2000). The serine-aspartate repeat (Sdr) family include SdrF
and SdrG in S. epidermidis and clumping factor A (ClfA),
ClfB, SdrC, SdrD, SdrE and Bbp in S. aureus (Josefsson
et al., 1998; McDevitt et al., 1994; Ni Eidhin et al., 1998;
Tung et al., 2000). S. aureus bone sialoprotein-binding pro-
tein (Bbp) is an allelic variant of SdrE (Peacock et al., 2002).
The members of Sdr family are predicted to adopt a similar
structural pattern (Trad et al., 2004). A secretary signal
sequence locates at the N-terminus followed by a ligand-
binding A region and a characterized R region composed of
SD repeats. The C-terminus features a cell wall-anchoring
motif including the conserved LPXTG sequence (W), a
hydrophobic membrane-spanning domain (M) and a short
positively charged cytoplasmic tail (C) (Downer, 2002). In
addition, SdrC, SdrD, SdrE and Bbp have different numbers
of B repeats inserted between region A and R with the
presence of a well-deﬁned 12 residues cation-binding EF-
hand loop (Josefsson et al., 1998). Our recent work showed
that B1 domain interacted with N2 domain and opened the
ligand binding cleft between N2 and N3 domains in SdrD
(Wang et al., 2013).
The gene identiﬁed from chromosomal DNA isolated from
S. aureus subsp. aureus TCH60 encodes bone sialoprotein-
binding protein (Bbp) with 1149 amino acids, containing SD-
repeats of 154 residues and the ligand-binding A region from
53 to 601 residues further divided into N1, N2 and N3
domains. S. aureus isolated from patients suffering from
septic arthritis and osteomyelitis speciﬁcally interacts with
bone sialoprotein (BSP), a noncollagenous protein of bone
and dentine extracellular matrix, mediated by Bbp (Ganss
et al., 1999; Ryden et al., 1987; Tung et al., 2000). BSP is
proposed to induce hydroxyapatite crystal formation and
distributes predominantly in the newly formed bone, which is
more likely to be infected (Hultenby, 1994; Hunter and
Goldberg, 1993).
Fibrinogen (Fg), a hexameric glycoprotein consisting of
three different chains α2, β2 and γ2, plays critical roles in blood
clotting and thrombosis (Gailit et al., 1997; Kollman et al.,
2009; Mosesson et al., 2001). ClfB binds to ﬁbrinogen α (Fg α)
chain (Ganesh et al., 2011; Xiang et al., 2012). ClfA and the
ﬁbronectin-binding proteins FnbpA and FnbpB all bind to the
C-terminal residues of ﬁbrinogen γ (Fg γ) chain (Rivera et al.,
2007; Wann et al., 2000). SdrG is reported to attack the
thrombin cleavage site of ﬁbrinogen β (Fg β) chain (Davis
et al., 2001). A “dock, lock and latch” (DLL) model is identiﬁed
in SdrG-Fg β complex to elucidate the ligand binding mecha-
nism, where the ligand docks in the opened groove between
N2 and N3 domains and the C-terminus across the groove
stretches into N2 domain (Ponnuraj et al., 2003).
As a bifunctional MSCRAMM, Bbp also recognizes
the human Fg α chain and inhibits thrombin induced blood
coagulation (Vazquez et al., 2011). The molecular basis for
Bbp-ligand interaction remains unknown. In our study, we
solved the crystal structuresof apo-Bbp273−598 andBbp273−598
complexed with the peptide of Fg α561−575. We described the
N2-N3domains ofBbp similar toDev-IgG fold (Deivanayagam
et al., 2002). TheBbp273−598-Fgα561−575 complex revealed the
ligand-binding basis through the rearrangement of the C-ter-
minus and the signiﬁcant changes in four regions. These
results advance our understanding of the ligand binding
mechanism of Bbp during S. aureus infection. Moreover, our
study should shed light on the further identiﬁcation of the
substrate or ligand of other closely related Sdr proteins, and
provide novel targets for the development of potent antago-
nists, vaccines or antibiotics.
RESULTS
Structure of apo-Bbp273−598
It was previously reported that on other MSCRAMMs of the
Sdr family, the ligand-binding region was mapped to the N2
and N3 domains of the N-terminal A region. Based on
sequence alignment of Bbp, SdrGandClfA (Davis et al., 2001;
Josefsson et al., 1998), we engineered a plasmid that would
generate a recombinant fusion protein covering residues
Asn273–Pro598 of Bbp from S. aureus, a segment containing
bothN2andN3domains (Fig. 1A), withN-terminalGST-tag for
puriﬁcation purposes in Escherichia coli. We obtained apo-
Bbp273−598 protein and solved the structure at 2.03 Å resolu-
tion (Table 1), consisting of residues Asn273–Leu584 and
additional residues Gly and Ser at N-terminus, two of the
remaining ﬁve amino acid residues (GPLGS) from digested
GST-tag (Fig. 1C). No electron density was observed for the
14 residues at C-terminus in the apo-Bbp273−598 structure.
The apo-Bbp273−598 folds into two distinct domains N2 and
N3, both of which have two layers of β-sheets and are struc-
turally similar to theDev-IgG fold (Fig. 1B), a variant of IgG fold
(Deivanayagam et al., 2002). The two β-sheets of the N2
domain are composed of A, B and E strands on one side and
C, D, D1, F and G strands on the opposite side. In N3 domain,
C′, D1′, D2′, F′ andG′ strands form one principal sheet and A′,
B′, D′ and E′ strands contribute to the facing sheet. The
additional D1′ and D2′ strands present the featured Dev-IgG
fold. One difference occurs with regard to the D strand in N2
domain, which parallels with E strand, although exhibiting an
antiparallel orientation with the corresponding strand in the
description of SdrG, ClfB and ClfA (Ganesh et al., 2008;
Ponnuraj et al., 2003; Xiang et al., 2012).
In the apo-Bbp273−598 structure, the C-terminus with poor
electron density extends into the solvent region, thus leading
to an open groove. Presumably, a ligand-binding site could
exist in the groove. (All structural ﬁgures in this paper were
generated by PyMOL).
Structure of the Bbp273−598-Fibrinogen α (Fg α)561−575
complex
The ITC result showed that Fg α561−575, a synthesized
polypeptide Fg α-chain containing residues 561–575
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(Vazquez et al., 2011), has binding afﬁnity to Bbp273−598 with
a KD of 0.290 μmol/L (Fig. 2A). To study the molecular
mechanism underlying Bbp-ligand recognition, Bbp273−598
was crystallized in complex with the ligand Fg α561−575. We
solved the crystal structure of Bbp273−598-Fg α561−575 com-
plex at 1.45 Å (Fig. 2B and Table 1).
Each crystallographic asymmetric unit contains two
independent Bbp273−598-Fg α561−575 molecules. The bound
peptide Fg α561−575 threads into the groove between the N2
and N3 domains in a snug conformation, with a well-deﬁned
2Fo-Fc electron density map observed for the residues
Lys562–Ser569 of the N-terminus of the peptide (Fig. 2C). The
six residues of the C-terminus of Fg α561−575 have few
interactions with the ligand binding groove and are not
traceable in the density map. Due to the poor side-chain
density, the N-terminal residue Fg αSer561 was replaced with
an Alanine during structure reﬁnement.
Structure comparison of Bbp273−598 between the apo-pro-
tein and in complex with the Fg α561−575 shows that the RMSD
for the Cα atoms is 0.679 Å. Even though the overall topology
of Bbp273−598 is similar in the two structures, signiﬁcant con-
formational changes were observed around the peptide-
binding groove, including the C-terminus of Bbp273−598
and four additional regions containing BbpAsp338–Gly355,
BbpThr365–Tyr387, BbpAla298–Gly301 in N2 domain and
BbpSer547–Gln561 in N3 domain, respectively (Fig. 3).
The structural basis for peptide binding
The disordered C-terminus encompassing residues Ser585–
Pro598 in apo-Bbp273−598 rearranges in the Bbp273−598-Fg
α561−575 structure. The connecting loop between the G′ and
G′′ strands spanning residues Thr586-Gly589 runs across the
central region of the groove and the following sequence
forms a short β-strand G′′ which inserts into N2
domain (Fig. 3A), making regions BbpAsp338–Gly355 and
BbpThr365–Tyr387 deviate signiﬁcantly from the apo-form
(Fig. 3B). It shows a deviation of 5.6 Å for BbpPro347 in the
region BbpAsp338–Gly355 between the C and D strands in N2
domain. BbpGly590 and Gly592 of β-strand G′′ of N3 domain
form two hydrogen bonds with BbpThr345 in this region. The
region BbpThr365–Tyr387 in N2 domain contains β-strand E and
the TYKFTDYVD sequence, a TYTFTDYVD-like motif con-
served in Sdr protein family (McCrea et al., 2000). The
β-strand E moves toward β-strand G′′ to stabilize the C-ter-
minus of N3 through several hydrogen bonds. BbpTyr387 in
this region interacts with BbpSer585 at the end of the G′














































Figure 1. Overall structure of the apo-Bbp273−598. (A) Domain organization of the Bbp molecule. S (amino acid 1–52), signal
sequence; N1–N3 (amino acid 53–601), Fg binding region; B (amino acid 602–935), B-repeats region; R (amino acid 936–1089),
serine-aspartate repeat region; W, wall-spanning domain; M, membrane anchor; C, cytoplasmic positively charged tail. The region of
N2 and N3 domains for crystallization (below). (B) Schematic representation of the topology of Bbp273−598 fold. The N2 and N3
domains are shown in cyan and violet, respectively. The N- and C-terminus are marked with red characters. (C) Cartoon
representation of apo-Bbp273−598 structure with its N- and C-terminus indicated. The N2 and N3 domains are shown in cyan and
violet, respectively.
Crystal structures of Bbp complex RESEARCH ARTICLE









C-terminus. BbpAsp373 and Arg374 in this region form two
hydrogen bonds with BbpLys597 to stabilize the tail of the
reordered C-terminus (Fig. 4A).
In addition, the binding of the peptide also induces a
reorganization of the region BbpAla298–Gly301 between the A
and B strands in N2 domain and a large movement of the
region BbpSer547–Gln561 between the E′ and F′ strands in N3
domain toward the peptide binding groove. Two newly
formed α-helices are observed in both of the two regions
(Fig. 3B). The residues BbpHis299 and Gly301 in the ﬁrst α-helix
interact with Fg αThr568 and Ser566 through two main-chain
hydrogen bonds and the BbpAsp300 forms the third hydrogen
bond with the side-chain of Fg αSer567. In the second α-helix,
BbpAsp555 contributes a hydrogen bond with Fg αLys562 and
the side chain of BbpLeu557 contacts with the aromatic ring of
Fg αPhe564 mediated by a hydrophobic interaction (Fig. 4B).
The structural rearrangements and the direct protein-li-
gand interactions formed upon peptide binding result in an
effectively stabilized Bbp-Fg α complex compared to its apo-
form.
Structural insights into Bbp273−598 and Fg α561−575
interactions
Apart from the interactions between the Fg α561−575 peptide
and the residues from the two newly formed α-helices we
have described above, there are several contacts with dis-
tances of less than 4 Å marked (Fig. 4B). Among them, there
are three pairs of antiparallel main-chain hydrogen bonds
between residues Fg αSer567, Thr565 and Gln563 and BbpThr582,
Leu584 and Thr586 in the G′ strand and the connecting loop
region. The carbonyl group of Fg αSer567 interacts with the
side-chain polar group of BbpAsn581 forming another hydro-
gen bond. The residue Fg αSer569 from the C-terminus of the
peptide forms a hydrogen bond with BbpThr580 in the G′
strand. The side chain hydroxyl group of Fg αSer566 interacts
with the backbone atom of BbpPhe433 in N3 domain and Fg
αSer566 forms the second hydrogen bond with the side-chain
carbonyl group of BbpAsp334 in N2 domain. Fg αPhe564 con-
tributes two hydrogen bonds with BbpAsp334 and Ile335 in the
loop region between the C and D strands in N2 domain. The
Table 1. Statistics of data collection and reﬁnement
Peptide free Fg α bound
Data collection
Space group I222 P21
a, b, c (Å) 96.241,98.924, 102.257 60.916, 74.961, 75.563
α, β, γ (°) 90.00, 90.00, 90.00 90.00, 102.91, 90.00
Wavelength (Å) 0.979 0.979
Resolution (Å) 2.03 (2.10–2.03) 1.45 (1.50–1.45)
Rmerge (%) 7.8 (44.8) 6.3 (75.5)
I/σ 15.6 (2.9) 26.8 (1.6)
Completeness (%) 96.8 (89.3) 99.2 (95.8)
Redundancy 3.7 (3.5) 5.1 (4.5)




No. atoms 2467 protein atoms + 172
solvent atoms + 2 Ca2+
5125 protein atoms + 1 Mg2+ + 159
peptide atoms + 1026 solvent atoms
B factors
Overall 38.794 21.274
RMSD bond lengths 0.008 0.006
RMSD bond angles 1.177 1.081
Ramachandran plot statistics (%)
In favored regions 96.5 98.9
In allowed regions 2.9 1.1
In disallowed regions 0.6 0.0
Values in parentheses are for the highest resolution shell. R = Σ|Fobs − Fcalc|/ΣFobs, where Fcalc is the calculated protein structure factor from the
atomic model (Rfree was calculated with 5% of the reﬂections selected).
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Figure 2. Overall structure of the Bbp273−598-Fg α561−575 complex. (A) ITC curves of Fg α561−575 titrated into Bbp273−598 protein.
The ﬁrst peak in the thermogram has not been used for analysis. (B) Cartoon representation of Bbp273−598-Fg α561−575 complex
structure with its N- and C-terminus indicated. The N2 and N3 domains are colored the same as in Fig. 1C. The peptide is shown as

















Figure 3. Conformational changes occur to C-terminus and additional four regions. (A) Surface charge representation of
Bbp273−598 binding with the Fg α561−575 peptide. The surface is colored depending on negative charge, electrically neutral area and
positive charge that are visualized in red, white and blue, respectively. Close view of surface and cartoon representation of C-terminus
of Bbp273−598 and the Fg α561−575 peptide shown as ribbon representation colored in cyan. The connecting loop is shown as cartoon
representation, composed of the residues Thr586–Ser589 running across the open groove are marked. (B) Structure alignment of
apo-Bbp273−598 and Bbp273−598-Fg α561−575 shows four changed regions. Apo-Bbp273−598 and Bbp273−598-Fg α561−575 are colored in
cyan and magenta, respectively. The peptide is shown as sticks colored in yellow. The regions BbpAsp338–Gly355, BbpThr365–Tyr387,
BbpAla298–Gly301 and BbpSer547–Gln561 of the Bbp273−598-Fg α561−575 complex are show in red, lemon, orange and blue, respectively.
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backbone atom of BbpAsn581 interacts with the carbonyl
group of Fg αSer569, which plays a signiﬁcant role in
anchoring the C-terminus of the Fg α561−575 peptide. Two
hydrogen bonds formed between the polar group of Fg
αGln563 and BbpAsp588 from the loop region are involved in
locking the peptide N-terminus.
Analysis of the interactions between Bbp273−598 mutants
and Fg α561−575
Mutagenesis studies were conducted to further verify the
binding of Fg α561−575 to Bbp273−598. We mutated the resi-
dues Thr582 and Leu584 to Ala respectively which form two
pairs of hydrogen bonds with the peptide. The mutant pro-
teins were puriﬁed to homogeneity and tested for their
interaction with the Fg α561−575 peptide by surface plasmon
resonance (SPR) (Fig. 5). The results indicate that the
mutated protein BbpT582A or BbpL584A exhibits higher binding
afﬁnities with the peptide than wild type (WT) Bbp273−598
protein. This is probably because the side chain of Ala
occupies less space compared to Thr or Leu, which brings
an alteration of steric hindrance. Thus, the alteration pre-
sumably makes the peptide more easily dock into the groove
and contacts more tightly with Bbp273−598. Even though
BbpThr582 and Leu584 could interact with the peptide by two
pairs of main chain-main chain hydrogen bonds (Fig. 3C),
the replacement to alanine might serve a similar role instead
of breaking the interaction with the peptide according to the
results here. Perhaps, we can speculate that the residues
BbpThr582 and Leu584 are only involved in the binding with the


































































Figure 4. Detailed interactions in the four changed regions. (A) Closer view of the interactions between the C-terminus of N3 and
the regions BbpAsp338–Gly355 and BbpThr365–Tyr387 of N2 in Bbp273−598-Fg α561−575; the residues involved are shown as sticks and
marked with red and black characters, respectively. The hydrogen bonds are indicated by magenta dashed lines. The peptide is
shown as sticks in yellow. (B) Detailed interactions between the ligand and Bbp273−598 in the Bbp273−598-Fg α561−575 complex.
Bbp273−598 and Fg α561−575 are shown as sticks, colored in magenta and yellow, respectively. The residues of Bbp273−598 and
Fg α561−575 are marked with black and red characters, respectively. The hydrogen bonds are indicated by green dashed lines.
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In this study, we have solved the crystal structures of apo-
Bbp273−598 and the Bbp273−598-Fg α561−575 complex. Based
on the structural information, we analyzed the structural
basis for ligand binding.
In our study, tight interactions between the protein and the
ligand result in a stable binding state. Due to the “Dock” of
the ligand, the rearrangements occur to C-terminus and
additional four regions of Bbp273−598. The connecting loop
covers the open groove, resulting in “Lock” of the ligand. And
then the G′′ strand forms compact interactions with the E
strand in the region BbpThr365–Tyr387 of N2 domain, which
“Latch” the ligand binding site and thus stabilize the overall
structure. Our structure further supports the DLL model
described for the SdrG-Fg β complex (Fig. 6A) (Ponnuraj
et al., 2003).
In the work of V. Ganesh et al. on the ClfB-ligand com-
plex, the ligand binding mechanism was described as the
“DL” model due to the absence of the “Latch” process
(Ganesh et al., 2011). In their structure, peptide Fg α336−347
in ClfB adopts a reverse orientation compared to the pep-
tide Fg α561−575 in our structure. The C-terminus of ClfB
does not stretch into N2 domain to interact with the E
strand but exhibits a different direction. Upon ligand bind-
ing, no rearrangements are observed in the region between
the D and D′ strands in N2 and the region between the E
and F strands in N3 (Fig. 6B). However, large movements
occur to the corresponding regions BbpAsp338–Gly355 in N2
and BbpSer547–Gln561 in N3 of Bbp273−598 in our studies. The
diversity of the ligands binding pattern of MSCRAMMs adds
to the necessity for structural analysis of individual mem-
bers of this family.
Altogether, our ﬁndings have promoted the understanding
of the ligand binding mechanism of Bbp in Sdr family, a
critical step in the S. aureus infection process. In addition,
potential new target sites based on these pathogen-host
interactions could be explored for development of potent
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Figure 5. SPR analyses of the interactions between Bbp273−598 WT and mutants (T582A and L584A) and the Fg α561−575
(A–C), respectively. The proteins were immobilized on a BIA-core sensor chip. The concentration of Fg α561−575 peptide ranges from
62.5 μmol/L to 0.976 μmol/L: Night blue, 62.5 μmol/L; Magenta, 31.25 μmol/L; Peach, 15.625 μmol/L; Bright blue, 7.812 μmol/L; Red,
3.9 μmol/L; Lime, 1.953 μmol/L; Black, 0.976 μmol/L. KD values of individual binding assays are indicated below the sensorgrams.
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Cloning, expression and puriﬁcation of the recombinant proteins
The fragment of the Bbp gene (corresponding to 273–598 aa) was
ampliﬁed using S. aureus ATCC 25923 genomic DNA by PCR. The
gene fragments of mutated proteins BbpT582A and BbpL584A followed
the same protocol. After digestion with BamHI and XhoI (NEB), the
ampliﬁed fragments were cloned into the prokaryotic expression
vector pGEX-6p-1 (GE Healthcare Life Sciences) to produce the
GST-Bbp fusion protein and were conﬁrmed by DNA sequencing.
The recombinant protein was expressed in Escherichia coli strain
BL21 with a high yield.
The bacteria cells were harvested and resuspended in lysis
buffer containing 1× PBS, 2 mmol/L DTT and 1 mmol/L PMSF. The
cells were homogenized by soniﬁcation and cell debris was removed
completely by centrifuging at 13,000 rpm for 50 min at 4°C.
The recombinant protein was ﬁrstly puriﬁed by GST-afﬁnity col-
umn and digested with PreScission protease overnight. The eluant
was collected and concentrated for further puriﬁcation using gel ﬁl-
tration chromatography (Superdex-200 column, GE Healthcare) in
buffer containing 20 mmol/L HEPES pH 7.5, 200 mmol/L NaCl, 2
mmol/L DTT on the FPLC system (GE Healthcare Life Sciences).
The proteins in every step of puriﬁcation were analyzed by SDS-
PAGE.
Crystallization and structure determination
The apo-Bbp273−598 and its complex were concentrated to 30 mg/mL
in 20 mmol/L HEPES pH 7.5, 200 mmol/L NaCl, 2 mmol/L DTT.
Crystals were screened by the sitting-drop vapor diffusion method
(Jancarik et al., 1991) using sparse-matrix screen kits Crystal
Screen I and II (Hampton Research), followed by optimizing the
crystallization conditions through the variation of protein concentra-
tions and pH. Crystals were grown at 18°C using the hanging-drop
vapor diffusion method by mixing 1.0 μL protein solution with 1.0 μL
reservoir solution and equilibrating against 200 μL reservoir solution.
The apo-Bbp273−598 crystals were grown in 0.2 mol/L calcium acet-
ate hydrate, 0.1 mol/L sodium cacodylate trihydrate pH 6.5, 18%
PEG8000. The synthesized Fg α561−575 peptide was added into the
concentrated protein samples at 10:1 ratio and the protein-peptide
complex crystals are grown in 0.2 mol/L lithium sulfate, 0.1 mol/L
Tris-HCl pH 8.2, 30% PEG4000. The apo-Bbp273−598 and
Bbp273−598-peptide complex crystals diffracted to 2.03 Å and 1.45 Å
respectively. The data were collected at the Shanghai Synchrotron
Radiation Facility (SSRF) BL17U using a MAR225 (MAR Research,
Hamburg) CCD detector at 100 K and processed with the HKL2000
package (Otwinowski and Minor, 1997). Further processing was
carried out using programs from the CCP4 suite (Collaborative
Computational Project, 1994). The model building of the Bbp273−598
molecules was conducted in COOT and the structure with peptide
was determined by molecular replacement methods in CCP4 (Em-
sley and Cowtan, 2004). All the structures were reﬁned with the
PHENIX packages (Adams et al., 2002). Data collection and struc-
ture statistic are summarized in Table 1.
Synthesis of Fg α561−575 chain peptide
The peptide corresponding to the ﬁbrinogen α561−575 was synthe-
sized as previously described (Vazquez et al., 2011).
Isothermal titration calorimetry
ITC experiments were carried out at 25°C using a Microcal
iTC200 instrument (GE Healthcare). The cell contained 50 μmol/L
Bbp273−598 and the syringe contained 500 μmol/L peptide in the
buffer containing 200 mmol/L NaCl and 20 mmol/L HEPES pH 7.5.
Injecting peptide into buffer was performed as the blank titration. The
data were ﬁtted and analyzed using the Origin 7 software package
(Microcal).
Surface plasmon resonance spectroscopy
The interaction afﬁnities between Fg α561−575 and Bbp273−598 protein
were conducted by surface plasmon resonance (SPR) using BIA-
core T200 instrument (GE Healthcare). The wild type Bbp273−598
protein and two mutants were immobilized, respectively, on a CM5
sensor chip in 10 mmol/L sodium acetate, pH 4.5. The immobiliza-
tion level was 3375RU. The synthetic peptide in 200 mmol/L NaCl














Figure 6. Structure comparison of Bbp, ClfB and SdrG.
(A) Superimposition of Bbp-Fg α and SdrG-Fg β (PDB entry:
1R17), colored in cyan and wheat, respectively. The peptides in
both structures are shown as cartoon. The C-termini of Bbp and
SdrG are indicated. (B) Superimposition of Bbp-Fg α and ClfB-
Fg α (PDB entry: 3AT0), colored in cyan and blue, respectively.
The peptides in both structures are shown as cartoon. The
C-termini of Bbp and ClfB are indicated.
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surface at various concentrations at 30 μL/min. The binding and
dissociation was 60 s and 120 s, respectively.
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